All the Right Moves: Oz Vows to Rein in MA Marketing, Prior Auth, Risk Adjustment

  • Mar 20, 2025

    Although Mehmet Oz, M.D., has yet to appear before a second Senate committee, if his smooth testimony before the U.S. Senate Finance Committee on March 14 is any indication, his confirmation as CMS administrator is almost assured. “There is no doubt you are qualified to serve as the next administrator…and I look forward to voting in favor of your nomination and am urging all of my colleagues to do the same,” Chairman Mike Crapo (R-Idaho) declared after Oz handily answered most of the senators’ questions.

    When asked by multiple senators (mostly Democrats, whose votes aren’t needed to clinch the nomination) about whether he is in favor of Medicaid cuts, Oz did not provide clear answers. Despite Oz declaring that he and President Donald Trump “love and cherish Medicare and Medicaid,” Sen. Ron Wyden (D-Ore.) was dissatisfied after digging in further and stated, “Let the record show that I asked a witness who said he cherishes this program will you agree to oppose cuts and he would not answer a yes or no question.” Oz did, however, firmly signal support for work requirements in Medicaid.

    Read more
    © 2024 MMIT
  • Lauren Flynn Kelly

    Lauren has been covering health business issues since the early 2000s and specializes in in-depth reporting on Medicare Advantage, managed Medicaid and Medicare Part D. She also possesses a deep understanding of the complex world of pharmacy benefit management, having written AIS Health’s Radar on Drug Benefits from 2004 to 2005 and again from 2011 to 2016. In addition to her role as managing editor of Radar on Medicare Advantage, she oversees AIS Health’s publications and manages the health editorial staff. She graduated from Vassar College with a B.A. in English.

The Latest
Meet Our Reporters

Meet Our Reporters

×